Study summary

The purpose of the study was to understand if there was benefit in continued treatment with a medicine called enzalutamide, when starting treatment with docetaxel and prednisolone (a standard chemotherapy for prostate cancer), after the prostate cancer had gotten worse when treated with enzalutamide alone.

Additional Study Details

Phase
Phase 3
Product
enzalutamide
Product
Enzalutamide
Docetaxel
Prednisolone
Placebo
Type
Interventional
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment number
688
Show Additional Study Details

Study documents

Scientific Results Summary 2
Available Language(s): English
Plain Language Summary
Available Language(s): English
Protocol
Available Language(s): English
Statistical Analysis Plan (SAP)
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site NO47004
    Stavanger, Norway, 4011
    Completed
    Site SE46004
    Uppsala, Sweden, 751 85
    Withdrawn
    Site BE32005
    Turnhout, Belgium, 2300
    Completed
    Site ES34007
    Malaga, Spain, 29010
    Completed
    Site RU70003
    Moscow, Russian Federation, 125284
    Completed
    Site RU70001
    Moscow, Russian Federation, 115478
    Completed
    Site GB44002
    Nottingham, United Kingdom, NG5 1PB
    Completed
    Site GB44004
    Cambridge, United Kingdom, CB2 0QQ
    Completed
    Site TR90003
    Istanbul, Turkey, 34722
    Completed
    Site ES34006
    Valencia, Spain, 46009
    Completed
    Site DE49004
    Wuppertal, Germany, 42103
    Completed
    Site GR30004
    Heraklion, Crete, Greece, 71403
    Completed
    Site DE49002
    Munster, Germany, 48149
    Completed
    Site FR33012
    Albi, France, 81000
    Completed
    Site PL48002
    Lodz, Poland, 93-513
    Completed
    Site ES34003
    Madrid, Spain, 28007
    Completed
    Site FR33005
    Suresnes, France, 92151
    Completed
    Site RU70002
    Moscow, Russian Federation, 105077
    Completed
    Site PL48005
    Warszawa, Poland, 04-141
    Withdrawn
    Site BE32008
    Wilrijk, Belgium, 2610
    Completed
    Site DE49017
    Ulm, Germany, 89075
    Completed
    Site GB44018
    Cardiff, United Kingdom, CF4 7XL
    Completed
    Site ES34008
    Santander, Spain, 39008
    Completed
    Site ES34001
    Madrid, Spain, 28040
    Completed
    Site FR33004
    Plerin, France, 22190
    Completed
    Site DE49008
    Aachen, Germany, 52074
    Completed
    Site DE49001
    Hannover, Germany, 30625
    Completed
    Site PL48004
    Gdańsk, Poland, 80-952
    Completed
    Site GB44014
    Exeter, United Kingdom
    Completed
    Site AT43001
    Vienna, Austria, 1090
    Completed
    Site ES34010
    Madrid, Spain
    Completed
    Site PL48006
    Warszawa, Poland, 02-507
    Completed
    Site IT39008
    Naples, Italy, 80131
    Completed
    Site IT39010
    Pavia, Italy, 27100
    Completed
    Site NO47005
    Drammen, Norway, 3004
    Completed
    Site GB44020
    Northwood, United Kingdom, HA62RN
    Completed
    Site RU70004
    Obninsk, Kaluga, Russian Federation, 24903
    Completed
    Site SE46005
    Kalmar, Sweden, 39185
    Completed
    Site FR33011
    Reims, France, 51056
    Completed
    Site GB44007
    Wirral, United Kingdom, CH63 4JY
    Completed
    Site GR30006
    Athens, Greece, 155 62
    Completed
    Site PL48003
    Krakow, Poland, 31-501
    Completed
    Site FR33002
    Nîmes, France, 30907 cedex 2
    Completed
    Site TR90001
    Ankara, Turkey, 06500
    Completed
    Site DE49015
    Tübingen, Germany, 72076
    Completed
    Site GB44003
    London, United Kingdom, SE1 9RT
    Completed
    Site NL31010
    Nieuwegein, Netherlands, 3435 CM
    Completed
    Site IT39002
    Terni, Italy, 05100
    Completed
    Site FR33008
    Paris, France, 75014
    Completed
    Site DE49018
    Nürtingen, Baden-Württemberg, Germany, 72622
    Completed
    Site ES34005
    Lugo, Lugo, Spain, 27003
    Completed
    Site IT39003
    Milano, Italy, 20100
    Completed
    Site CH41005
    Locarno, Tessin, Switzerland, 6600
    Completed
    Site IT39004
    Rome, Italy, 161
    Completed
    Site RU70005
    St. Petersburg, Russian Federation, 197022
    Completed
    Site NO47001
    Kristiansand, Norway, 4615
    Completed
    Site CZ42004
    Brno, Czech Republic, 656 91
    Completed
    Site IT39001
    Arezzo, Arezzo, Italy, 52100
    Withdrawn
    Site FR33006
    Vandoeuvre les Nancy, France, 54511
    Completed
    Site NL31002
    Amsterdam, Netherlands, 1066 CX
    Completed
    Site GB44015
    Norwich, United Kingdom, NR4 7UY
    Completed
    Site TR90002
    Izmir, Turkey, 35340
    Completed
    Site CH41009
    Zurich, Zurich, Switzerland, CH-8038
    Completed
    Site CZ42003
    Olomouc, Czech Republic, 77520
    Completed
    Site NL31003
    Rotterdam, Netherlands, 3045 PM
    Completed
    Site GR30001
    Heraklion, Crete, Greece, 70013
    Withdrawn
    Site IT39013
    Rome, Italy, 00152
    Completed
    Site ES34009
    Murcia, Spain, 30008
    Completed
    Site GB44010
    Aberdeen, United Kingdom, AB25 2ZN
    Completed
    Site BE32004
    Ottignies, Belgium, 1340
    Completed
    Site CZ42001
    Praha 2, Czech Republic, 12808
    Completed
    Site GB44017
    Swansea, United Kingdom, SA2 8QA
    Completed
    Site ES34002
    Madrid, Spain, 28041
    Completed
    Site FR33013
    Quimper, France, 29000
    Completed
    Site DE49006
    Heidelberg, Germany, 69120
    Completed
    Site BE32002
    Liege, Belgium, 4000
    Completed
    Site FR33003
    Montpellier, France, 34298 cedex 5
    Completed
    Site DE49010
    Bergisch Gladbach, Germany, 51465
    Completed
    Site SE46003
    Solna, Sweden, 171 76
    Completed
    Site SE46002
    Göteborg, Sweden, 413 45
    Completed
    Site ES34004
    Sevilla, Spain, 41013
    Completed
    Site RU70006
    St. Petersburg, Russian Federation, 197758
    Completed
    Site BE32003
    Bonheiden, Belgium, 2820
    Completed
    Site CZ42002
    Plzeň -Lochotín, Czech Republic, 30460
    Completed
    Site DE49003
    Mannheim, Germany, 68167
    Completed
    Site FR33014
    Paris, France, 75014
    Completed
    Site NL31007
    Blaricum, Netherlands, 1261 AN
    Completed
    Site IT39012
    Brescia, Italy, 25126
    Completed
    Site AT43004
    Linz, Austria, 4010
    Completed
    Site GR30003
    Athens, Greece, 14564
    Completed
    Site NL31004
    Hoofddorp, Netherlands, 2134 TM
    Completed
    Site GR30005
    Thessaloniki, Greece, 54007
    Completed
    Site IT39005
    Roma, Italy, 00128
    Withdrawn
    Site GR30002
    Larissa, Greece, 41110

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?